Szostak M Anne's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed May 23, 2025
- Accession no.
- 0000874716-25-000094
- Filed
- May 23, 2025
- Trade date
- May 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.18M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Szostak M AnneCIK 0001094176 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Common Stock | MOption exerciseAcquired | +1,046 | $160.28 | +$167,652.88 | 1,308 | Direct | |
| May 21, 2025 | Common Stock | SSaleDisposed | −1,046 | $513.74 | −$537,372.04 | 262 | Direct | |
| May 21, 2025 | Common Stock | SSaleDisposed | −1,260 | $512.34F1 | −$645,548.4 | 1,801 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Common Stock | MOption exerciseDisposed | −1,046 | –F4 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold ranging from a low of $511.81 to a high of $512.61 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Not applicable.
Referenced by the price of 1 transaction in Table II.